ReviewReviews in cardiovascular medicine2026

Lipid Metabolism as a Therapeutic Target in Arrhythmogenic Cardiomyopathy: Emerging Therapeutic Implications of Lipid-Lowering Therapy.

Nicolò Pasini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.